The Candida Genome Database (CGD), a community resource for Candida albicans gene and protein information

被引:90
作者
Arnaud, MB [1 ]
Costanzo, MC [1 ]
Skrzypek, MS [1 ]
Binkley, G [1 ]
Lane, C [1 ]
Miyasato, SR [1 ]
Sherlock, G [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA
关键词
D O I
10.1093/nar/gki003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Candida Genome Database (CGD) is a new database that contains genomic information about the opportunistic fungal pathogen Candida albicans. CGD is a public resource for the research community that is interested in the molecular biology of this fungus. CGD curators are in the process of combing the scientific literature to collect all C.albicans gene names and aliases; to assign gene ontology terms that describe the molecular function, biological process, and subcellular localization of each gene product; to annotate mutant phenotypes; and to summarize the function and biological context of each gene product in free-text description lines. CGD also provides community resources, including a reservation system for gene names and a colleague registry through which Candida researchers can share contact information and research interests. CGD is publicly funded (by NIH grant R01 DE1587301 from the NIDCR) and is freely available at http://www.candidagenome.org/.
引用
收藏
页码:D358 / D363
页数:6
相关论文
共 14 条
  • [1] Gene Ontology: tool for the unification of biology
    Ashburner, M
    Ball, CA
    Blake, JA
    Botstein, D
    Butler, H
    Cherry, JM
    Davis, AP
    Dolinski, K
    Dwight, SS
    Eppig, JT
    Harris, MA
    Hill, DP
    Issel-Tarver, L
    Kasarskis, A
    Lewis, S
    Matese, JC
    Richardson, JE
    Ringwald, M
    Rubin, GM
    Sherlock, G
    [J]. NATURE GENETICS, 2000, 25 (01) : 25 - 29
  • [2] BENNETT JE, 1996, GOODMAN GILMANS PHAR, P1165
  • [3] Thirteen-year evolution of azole resistance in yeast isolates and prevalence of resistant strains carried by cancer patients at a large medical center
    Boschman, CR
    Bodnar, UR
    Tornatore, MA
    Obias, AA
    Noskin, GA
    Englund, K
    Postelnick, MA
    Suriano, T
    Peterson, LR
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (04) : 734 - 738
  • [4] Saccharomyces Genome Database (SGD) provides tools to identify and analyze sequences from Saccharomyces cerevisiae and related sequences from other organisms
    Christie, KR
    Weng, S
    Balakrishnan, R
    Costanzo, MC
    Dolinski, K
    Dwight, SS
    Engel, SR
    Feierbach, B
    Fisk, DG
    Hirschman, JE
    Hong, EL
    Issel-Tarver, L
    Nash, R
    Sethuraman, A
    Starr, B
    Theesfeld, CL
    Andrada, R
    Binkley, G
    Dong, Q
    Lane, C
    Schroeder, M
    Botstein, D
    Cherry, JM
    [J]. NUCLEIC ACIDS RESEARCH, 2004, 32 : D311 - D314
  • [5] CAN WE PREVENT AZOLE RESISTANCE IN FUNGI
    DENNING, DW
    [J]. LANCET, 1995, 346 (8973): : 454 - 455
  • [6] OPPORTUNISTIC CANDIDIASIS - AN EPIDEMIC OF THE 1980S
    FISHERHOCH, SP
    HUTWAGNER, L
    [J]. CLINICAL INFECTIOUS DISEASES, 1995, 21 (04) : 897 - 904
  • [7] Antifungal agents: Chemotherapeutic targets and immunologic strategies
    Georgopapadakou, NH
    Walsh, TJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (02) : 279 - 291
  • [8] Emerging targets for the development of novel antifungal therapeutics
    Groll, AH
    De Lucca, AJ
    Walsh, TJ
    [J]. TRENDS IN MICROBIOLOGY, 1998, 6 (03) : 117 - 124
  • [9] EMERGENCE OF AZOLE DRUG-RESISTANCE IN CANDIDA SPECIES FROM HIV-INFECTED PATIENTS RECEIVING PROLONGED FLUCONAZOLE THERAPY FOR ORAL CANDIDOSIS
    JOHNSON, EM
    WARNOCK, DW
    LUKER, J
    PORTER, SR
    SCULLY, C
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 35 (01) : 103 - 114
  • [10] The diploid genome sequence of Candida albicans
    Jones, T
    Federspiel, NA
    Chibana, H
    Dungan, J
    Kalman, S
    Magee, BB
    Newport, G
    Thorstenson, YR
    Agabian, N
    Magee, PT
    Davis, RW
    Scherer, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (19) : 7329 - 7334